APA (7th ed.) Citation

YN, G., KJ, P., YM, Z., YB, Q., WG, C., T, Z., . . . J, L. (2025). Tofacitinib prevents depressive-like behaviors through decreased hippocampal microgliosis and increased BDNF levels in both LPS-induced and CSDS-induced mice. Acta pharmacologica Sinica, 46(2), 353. https://doi.org/10.1038/s41401-024-01384-8

Chicago Style (17th ed.) Citation

YN, Gao, et al. "Tofacitinib Prevents Depressive-like Behaviors Through Decreased Hippocampal Microgliosis and Increased BDNF Levels in Both LPS-induced and CSDS-induced Mice." Acta Pharmacologica Sinica 46, no. 2 (2025): 353. https://doi.org/10.1038/s41401-024-01384-8.

MLA (9th ed.) Citation

YN, Gao, et al. "Tofacitinib Prevents Depressive-like Behaviors Through Decreased Hippocampal Microgliosis and Increased BDNF Levels in Both LPS-induced and CSDS-induced Mice." Acta Pharmacologica Sinica, vol. 46, no. 2, 2025, p. 353, https://doi.org/10.1038/s41401-024-01384-8.